Sanofi gets serious in China with plans to hire 300 for $76M R&D site in Chengdu
Several big pharmas have recently shuttered their research operations in China, but Sanofi is apparently buckling down in the region with a new global R&D hub. The company is hiring 300 people in Chengdu, China to run a tech-focused operation that’s meant to speed up analysis of its clinical trials.
Sanofi is investing €66 million ($76.6 million) in the hub and will have it fully staffed by 2020. The R&D center is supposed to support Sanofi’s drug development by managing global multi-center clinical trial data and files. The company says it will “take advantage of local talents” to strengthen Sanofi’s digital capabilities, speeding up trials results.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.